Research Highlight | Published:

ALZHEIMER DISEASE

Alzheimer disease mice improve with CRISPR–Cas9 gene editing

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

    Original article

    1. Park, H. et al. In vivo neuronal gene editing via CRISPR–Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer’s disease. Nat. Neurosci. https://doi.org/10.1038/s41593-019-0352-0 (2019)

    Download references

    Author information

    Correspondence to Ian Fyfe.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark